Healthcare technology company Cue Health announced that it closed a private financing round worth $235 million. Existing investors Johnson & Johnson Innovation — JJDC, Decheng Capital, CAVU Ventures, ACME Capital and more contributed to the financing, as did new investors Perceptive Advisors, MSD Capital and Koch Strategic Platforms, according to a news release. Morgan Stanley […]
Search Results for: point-of-care
Abbott sees a future for at-home diagnostics after COVID-19
Abbott CEO Robert B. Ford has suggested that at-home diagnostics could be here to stay even after the COVID-19 pandemic. Speaking on Abbott’s April 20 earnings call, transcribed by SeekingAlpha, Ford pointed out that the company’s diagnostics sales increased by 115% year-over-year from the first quarter of 2020, with a significant chunk of that made […]
FDA issues EUA for single-use, OTC PCR COVID-19 at-home test
Lucira Health announced today that it received FDA emergency use authorization (EUA) for over-the-counter sales of its COVID-19 test kit. Emeryville, Calif.-based Lucira’s PCR molecular test kit, the Lucira Check It kit, is designed to deliver results in 30 minutes or less at home. The authorization covers those with symptoms and those without, and the […]
LumiraDx to start trading on Nasdaq through $5B SPAC deal
CA Healthcare Acquisition Corp.— a special purpose acquisition company — announced today that it entered a merger agreement with LumiraDx that will take the company public. London-based LumiraDx, a point-of-care diagnostics developer, will merge with CAHC with the combination reflecting a value of $5 billion for Lumira’s existing equity, according to a news release. Since […]
Inflammatix raises $102M
Inflammatix announced last month that it closed a $102 million Series D financing round to support its diagnostics portfolio. Burlingame, Calif.-based Inflammatix develops a molecular diagnostic designed to read the patient’s immune system to deliver rapid results, with an initial focus on acute infection and sepsis. Its HostDx tests combine proprietary biomarkers and advanced machine […]
FDA authorizes use of over-the-counter COVID-19 tests for screening
The FDA announced today that it authorized several COVID-19 tests for over-the-counter use in asymptomatic screening. Among the tests authorized were the BinaxNow Ag card from Abbott (which includes point-of-care screening) and the Quidel Quick-View at-home test. FDA also authorized the BD Veritor Plus system for POC screening with a prescription. “BD is supporting the […]
BD lands EUA for COVID/flu test
The FDA issued a letter to BD (NYSE:BDX) to confirm the emergency use authorization of its Veritor system for detecting COVID-19 and flu. According to the letter, dated last week, the Veritor system was authorized for the simultaneous qualitative detection and differentiation of SARS-CoV-2 nucleocapsid antigen and/or influenza A and B nucleoprotein antigens directly from […]
BrainScope launches next-gen concussion diagnostic device
BrainScope announced that it launched its third FDA-cleared algorithm for concussion diagnosis on the BrainScope device. Bethesda, Md.–based BrainScope’s Concussion Index is the first physiological marker of concussive injury that aids clinicians in the assessment of patients at baseline, point of injury and through recovery, according to a news release. The index adds to BrainScope’s […]
Calumeo launches dry-heat N95 reprocessor
Calumeo today announced the U.S. launch of a point-of-care N95 mask reprocessing device. The Morgan Hill-Calif.-based company said its Calumeo Clean countertop device uses dry heat to decontaminate N95 masks for reuse, without the use of toxic chemicals. The process takes just over an hour. The device can process six masks at a time and each […]
BD partners with ImageMover for COVID-19 test mobile app
Becton Dickinson (NYSE:BDX) announced today that it entered into an agreement with ImageMover to offer a mobile app for COVID-19 testing. Franklin Lakes, N.J.-based Becton Dickinson’s agreement enables the ImageMover software platform to simplify medical data collection and management through a companion mobile app for SARS-CoV-2 antigen testing performed on the BD Veritor Plus system, […]
Philips, DiA partner on AI-based applications for ultrasound
Philips (NYSE: PHG, AEX: PHIA) announced today that it has formed a strategic partnership with DiA Imaging Analysis to incorporate DiA’s AI library of automated solutions with Philips ultrasound. Be’er Sheva, Israel–based DiA’s AI-enabled 2D ultrasound applications have FDA clearance and a CE Mark. The applications are geared toward reducing variability and increasing the efficiency […]
